Have $3,000? Buying These 2 Stocks Would Be the Smartest Move You Ever Made
Both companies are using nanotechnology to revolutionize healthcare and manufacturing. Plus, they have considerable upside.
Up 938% in 2020, Is Co-Diagnostics Still a Buy in 2021?
This diagnostic specialist started off the year as a micro cap, but it roared ahead with its COVID-19 test.
Activision Blizzard: Buy or Sell?
It's possible that Wall Street has the wrong idea about what kind of company this video game publisher really is.
Why the Market Is So Bullish About Trillium Therapeutics
The cancer biotech soared in 2020, jumping up over 1,000% for the year. What will the stock do in 2021?
After Its 1,500% Jump, Is It Time to Sell Vaxart Stock?
After the stock's magnificent run in 2020, it might be time to take profits.
Why the No. 1 Healthcare Stock of 2020 Is Still a Buy
Novavax has significant upside if its phase 3 data are positive.
Is It Too Late to Get In On This Millionaire-Making Stock?
While it's already made some people rich, Axsome Therapeutics is just getting started.
Top 5 Healthcare Stocks of 2020: Are They Buys Now?
These five winners in the healthcare space were all micro-caps at the beginning of the year. How big can they get?
If You Invested $10,000 in Personalis in the Coronavirus Crash, This Is How Much You'd Have Now
Investors weren't very happy when shares tanked in March, but have been smiling ever since.
Why I'm Not Buying Vaxart Stock
There are some warning signs around this vaccine-maker that investors should take seriously.
Ubisoft Joins With Disney to Develop New 'Star Wars' Game
Now Ubisoft is hard at work on two Disney properties with massive upside: "Star Wars" and "Avatar."
Will IMAX Keep Losing in 2021?
The stock dropped 13% in 2020. Will it recover this year?
The 10 Best-Performing Stocks of 2020
Biotech, bitcoin, and renewable energy led the way.
My 2 Top Small-Cap Stocks to Own In 2021
Silvergate Capital and Ontrak have massive runways for growth in the new year.
Here's Why You Should Really Own DermTech Stock in 2021
The biotech's skin cancer diagnostic tool is a significant improvement over the standard of care.
This Stock Could Be a Surprise Growth Pick for 2021
Down 77% in 2020, Amarin's stock should zoom higher once Vascepa obtains European approval.
Investors in This One Stock Had an Amazing Year
Novavax had the highest returns of any stock on the market in 2020.
Here's a Cancer-Killing Stock to Buy for 2021
"Natural killer" (or NK) cancer therapies are hot right now. Here are two stocks that are early leaders in the field -- one is a buy, and the other one is not.
Why Is Everybody Talking About Novavax Stock?
Its coronavirus vaccine could make it an even bigger winner.
Why Peter Lynch Would Love Freshpet Stock
This dog food stock has been an incredible 16-bagger over the last five years.